Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4101 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024

Home Care Ontario Honours 40 Home Care Heroes

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024

Going Global: Bringing Drugs for Depression to Market in the US and EU, Upcoming Webinar Hosted by Xtalks

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024
Related companies:  Xtalks

How Labor Shortages and Telehealth Impact HCP Targeting: Best Practices Using Claims Insights, Upcoming Webinar Hosted by Xtalks

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024
Related companies:  Xtalks

NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024
Related companies:  Nanalysis Scientific Corp.

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024

Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital Partners

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024

STATEMENT - CMA seriously concerned about the future of family medicine in Quebec

Read more ››
By: PR Newswire Association LLC. - 20 Mar 2024

Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of Ophthalmology

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Nicox S.A.

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  BioNTech SE

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  BioNTech SE

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Amicus Therapeutics, Inc.

LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Lava Therapeutics N.V.

ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  ACELYRIN INC.

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Cabaletta Bio, Inc.

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  TELA Bio, Inc

OKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  OKYO Pharma Limited

BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  BioCardia, Inc.

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Orchard Therapeutics plc

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Avid Bioservices, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑